These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 6163685)
1. [Fetal and placental proteins in ovarian cancer]. Tatra G; Ludwig H Gynakol Rundsch; 1980 Jun; 20 Suppl 2():138-41. PubMed ID: 6163685 [No Abstract] [Full Text] [Related]
2. Oncofetal and oncoplacental antigens as tumor markers. Yamauchi S; Miyake H Kitasato Arch Exp Med; 1988 Sep; 61(2-3):95-109. PubMed ID: 2463397 [No Abstract] [Full Text] [Related]
3. [Serum markers in malignant diseases]. Peter HH Med Lab (Stuttg); 1981 Nov; 34(11):262-71. PubMed ID: 6176842 [No Abstract] [Full Text] [Related]
4. Editorial: When is a tumor marker not a tumor marker? Vaitukaitis JL N Engl J Med; 1975 Dec; 293(26):1370-1. PubMed ID: 52844 [No Abstract] [Full Text] [Related]
5. Tumour markers in ovarian cancer. van Nagell JR Clin Obstet Gynaecol; 1983 Aug; 10(2):197-212. PubMed ID: 6193919 [No Abstract] [Full Text] [Related]
7. Serial determination of marker substances in ovarian cancer. Stanhope CR; Smith JP; Britton JC; Crosley PK Gynecol Oncol; 1979 Dec; 8(3):284-7. PubMed ID: 92437 [No Abstract] [Full Text] [Related]
8. [Significance of the contemporary determination of tumor associated antigens in patients with various types of neoplasms of the genital tract]. Sacco F; Benedetti Panici P; Villani L; Di Roberto P; Barile G; Iacobelli S Minerva Ginecol; 1978 Oct; 30(10):811-6. PubMed ID: 82920 [No Abstract] [Full Text] [Related]
9. Biochemical markers in gynaecological cancer. Farrell RJ Ir Med J; 1980 Aug; 73(8):285-6. PubMed ID: 6161106 [No Abstract] [Full Text] [Related]
10. Tumor markers in the ovarian carcinoma. Margariti PA; Benedetti Panici P; Villani L; Di Roberto P; Maiorca A; Sacco F; Bompiani A Eur J Gynaecol Oncol; 1980 May; 1(2):77-9. PubMed ID: 6174341 [No Abstract] [Full Text] [Related]
11. Biological markers in gynecologic cancers. An overview. Dini MM; Miller M IMJ Ill Med J; 1984 Sep; 166(3):166-71. PubMed ID: 6208177 [No Abstract] [Full Text] [Related]
12. Significance of tumour markers in ovarian cancer. Bhatavdekar JM; Shah NG; Trivedi SN; Karelia NH Indian J Cancer; 1987 Mar; 24(1):1-8. PubMed ID: 2448222 [No Abstract] [Full Text] [Related]
13. [Tumor markers in oncological gynecology]. Vishnevskiĭ AS Vopr Onkol; 1984; 30(8):23-34. PubMed ID: 6207663 [No Abstract] [Full Text] [Related]
15. The detection and measurement of oncodevelopmental proteins in gynecological malignant disease. Cerni C; Tatra G Arch Gynecol; 1982; 231(2):159-65. PubMed ID: 6176191 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical localization of tumor markers in epithelial ovarian cancer. Casper S; van Nagell JR; Powell DF; Dubilier LD; Donaldson ES; Hanson MB; Pavlik EJ Am J Obstet Gynecol; 1984 May; 149(2):154-8. PubMed ID: 6202143 [TBL] [Abstract][Full Text] [Related]
17. Tumor associated markers in clinical diagnosis. Rochman H Ann Clin Lab Sci; 1978; 8(3):167-75. PubMed ID: 77652 [No Abstract] [Full Text] [Related]
18. [Placental and embryonal proteins as antigens in the immunodiagnosis of malignant tumors]. Tatarinov IuS Vestn Akad Med Nauk SSSR; 1977; (10):90-3. PubMed ID: 72463 [No Abstract] [Full Text] [Related]
19. Preneoplasia and neoplasia of the bronchus, esophagus, and colon: the use of markers in determining phenotypes and classification. Trump BF; McDowell EM; Shamsuddin AK; Phelps PC; Purnell DM; Wilson TS; Banks-Schlegel SP; Kurland CL; Harris CC Monogr Pathol; 1985; (26):101-39. PubMed ID: 2414648 [No Abstract] [Full Text] [Related]
20. Tumour antigens associated with primary mediastinal choriocarcinoma. Forest JC; Talbot J; Pagé M; Loiselle JM Can Med Assoc J; 1977 Dec; 117(12):1386-8. PubMed ID: 73406 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]